1. COVID-19 Presenting With Diabetic Ketoacidosis: A Case Series
- Author
-
Sandeep Dhindsa, Ravi P. Nayak, Ghassan Kamel, and Ramya S. Gorthi
- Subjects
Pediatrics ,medicine.medical_specialty ,Diabetic ketoacidosis ,endocrine system diseases ,type 2 diabetes mellitus ,SARS-CoV, severe acute respiratory syndrome coronavirus ,030209 endocrinology & metabolism ,Case Report ,Diseases of the endocrine glands. Clinical endocrinology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,diabetic ketoacidosis ,law ,Diabetes mellitus ,Severity of illness ,medicine ,DKA, diabetic ketoacidosis ,Type 1 diabetes ,COVID-19, coronavirus disease-2019 ,business.industry ,T1DM, type 1 diabetes mellitus ,Type 2 Diabetes Mellitus ,nutritional and metabolic diseases ,COVID-19 ,General Medicine ,T2DM, type 2 diabetes mellitus ,medicine.disease ,GI, gastrointestinal ,RC648-665 ,Intensive care unit ,030220 oncology & carcinogenesis ,Concomitant ,SARS-CoV2 ,Etiology ,SARS-CoV2, Severe Acute Respiratory Syndrome coronavirus 2 ,business ,type 1 diabetes mellitus - Abstract
Objective Diabetes mellitus has been recognized as one of the comorbidities that predict the severity of illness in patients infected with COVID-19. The characteristics of patients presenting with diabetic ketoacidosis (DKA) and COVID-19 infection have not been described. Methods We describe 5 patients with DKA and concomitant COVID-19 admitted to the intensive care unit of an academic medical center. Three patients had type 1 diabetes mellitus, and 2 patients had type 2 diabetes mellitus. Results While DKA with an infectious etiology is a common presentation, we observed that the patients with DKA precipitated by COVID-19 presented with atypical symptoms. COVID-19 infection was revealed during search for an etiology of DKA. Conclusion It is prudent to have a low threshold to screen for COVID-19 infection in patients with DKA.
- Published
- 2021